生物
细胞生物学
核糖核酸
坦克结合激酶1
内部收益率3
钻机-I
RNA结合蛋白
干扰素
分子生物学
蛋白激酶A
核糖核蛋白
激酶
先天免疫系统
病毒学
生物化学
免疫系统
丝裂原活化蛋白激酶激酶
遗传学
基因
作者
Alexander Kirchhoff,Anna‐Maria Herzner,Christian Urban,Antonio Piras,Robert Düster,Julia Mahlberg,Agathe Grünewald,Thais Marina Schlee-Guimaraes,Katrin Ciupka,Petro Leka,Robert J. Bootz,Christina Wallerath,Charlotte Hunkler,Ann Kristin de Regt,Beate M. Kümmerer,Maria H Christensen,Florian I. Schmidt,Min Ae Lee-Kirsch,Claudia Günther,Hiroki Kato
标识
DOI:10.1038/s44318-024-00331-x
摘要
Abstract The cytosolic nucleic acid sensors RIG-I and cGAS induce type-I interferon (IFN)-mediated immune responses to RNA and DNA viruses, respectively. So far no connection between the two cytosolic pathways upstream of IKK-like kinase activation has been investigated. Here, we identify heterogeneous nuclear ribonucleoprotein M (hnRNPM) as a positive regulator of IRF3 phosphorylation and type-I IFN induction downstream of both cGAS and RIG-I. Combining interactome analysis with genome editing, we further uncover the RNA-binding protein ELAV-like protein 1 (ELAVL1; also known as human antigen R, HuR) as an hnRNPM interactor. Depletion of hnRNPM or ELAVL1 impairs type-I IFN induction by herpes simplex virus 1 or Sendai virus. In addition, we show that hnRNPM and ELAVL1 interact with TANK-binding kinase 1, IκB kinase ε, IκB kinase β, and NF-κB p65. Our confocal microscopy experiments demonstrate cytosolic and perinuclear interactions between hnRNPM, ELAVL1, and TBK1. Furthermore, pharmacological inhibition of ELAVL1 strongly reduces cytokine release from type-I interferonopathy patient fibroblasts. The RNA-binding proteins hnRNPM and ELAVL1 are the first non-redundant regulators to bridge the cGAS/STING and RIG-I/MAVS pathways. Overall, our study characterizes the hnRNPM-ELAVL1 complex as a novel system promoting antiviral defense, pointing to a potential therapeutic target to reduce auto-inflammation in patients with type-I interferonopathies.
科研通智能强力驱动
Strongly Powered by AbleSci AI